unknown
Stage
About
Humacyte develops bioengineered, off-the-shelf human acellular vessels (HAVs) for use as implantable blood vessels to treat vascular disease and provide durable vascular access for dialysis and other indications.
Explore Humacyte's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.